Metraipolis › archive › dc_6bcd77417cbc
WT1-pulsed dendritic cell vaccination for neovascular age-related macular degeneration: a phase I pilot feasibility study — Europe PMC PMID:42177462
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42177462
- DOI
- 10.1186/s12886-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:06:48.921Z
- SHA-256 of the archived text
03e42f1e7d17ad99938521ded815f071135c4d1788df82dbde5a5abea8f4f378- Stable URL of this page
https://metraipolis.com/documento/dc_6bcd77417cbc
How to cite
WT1-pulsed dendritic cell vaccination for neovascular age-related macular degeneration: a phase I pilot feasibility study — Europe PMC PMID:42177462 — Europe PMC (en), https://europepmc.org/article/MED/42177462 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6bcd77417cbc (Metraipolis archive dc_6bcd77417cbc, sha256 03e42f1e7d17ad99938521ded815f071135c4d1788df82dbde5a5abea8f4f378)
BibTeX
@misc{dc6bcd77417cbc,
title = {WT1-pulsed dendritic cell vaccination for neovascular age-related macular degeneration: a phase I pilot feasibility study — Europe PMC PMID:42177462},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42177462},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6bcd77417cbc; sha256 03e42f1e7d17ad99938521ded815f071135c4d1788df82dbde5a5abea8f4f378},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42177462. Agents can read the archived copy with the MCP tool read_document.